IT1107675B - Procedimento per la produzione di derivati ammidici in particolare acilanilidi sostituite e prodotto ottenuto - Google Patents

Procedimento per la produzione di derivati ammidici in particolare acilanilidi sostituite e prodotto ottenuto

Info

Publication number
IT1107675B
IT1107675B IT52280/78A IT5228078A IT1107675B IT 1107675 B IT1107675 B IT 1107675B IT 52280/78 A IT52280/78 A IT 52280/78A IT 5228078 A IT5228078 A IT 5228078A IT 1107675 B IT1107675 B IT 1107675B
Authority
IT
Italy
Prior art keywords
acylanylides
procedure
production
obtained product
particular substituted
Prior art date
Application number
IT52280/78A
Other languages
English (en)
Italian (it)
Other versions
IT7852280A0 (it
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of IT7852280A0 publication Critical patent/IT7852280A0/it
Application granted granted Critical
Publication of IT1107675B publication Critical patent/IT1107675B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/115—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • C07C59/315—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups containing halogen
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B31/00—Associated working of cameras or projectors with sound-recording or sound-reproducing means
    • G03B31/02—Associated working of cameras or projectors with sound-recording or sound-reproducing means in which sound track is on a moving-picture film

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT52280/78A 1977-12-15 1978-12-13 Procedimento per la produzione di derivati ammidici in particolare acilanilidi sostituite e prodotto ottenuto IT1107675B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5222377 1977-12-15

Publications (2)

Publication Number Publication Date
IT7852280A0 IT7852280A0 (it) 1978-12-13
IT1107675B true IT1107675B (it) 1985-11-25

Family

ID=10463104

Family Applications (1)

Application Number Title Priority Date Filing Date
IT52280/78A IT1107675B (it) 1977-12-15 1978-12-13 Procedimento per la produzione di derivati ammidici in particolare acilanilidi sostituite e prodotto ottenuto

Country Status (21)

Country Link
US (1) US4191775A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0002892B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5495519A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT360974B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU522716B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG31225A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1123008A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS208112B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD139844A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2862459D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK556978A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES476049A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI70007C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU176981B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE49866B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL56155A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1107675B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO149035C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ189086A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT68922A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA786781B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197008A (en) * 1980-05-22 1984-10-19 Ici Ltd Acylanilide derivatives and pharmaceutical compositions
AU8961382A (en) * 1981-11-06 1983-05-12 Imperial Chemical Industries Plc Amide derivatives
GB8504093D0 (en) * 1985-02-18 1985-03-20 Ici Plc Alkene alkyne/cycloalkylene derivatives
US5236953A (en) * 1982-04-14 1993-08-17 Imperial Chemical Industries Plc Alkene, alkyne or cycloalkylene derivatives
LU88769I2 (fr) * 1982-07-23 1996-11-05 Zeneca Ltd Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
US4885289A (en) * 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
GB8406000D0 (en) * 1984-03-07 1984-04-11 Ici Plc Olefine derivatives
GB8617652D0 (en) * 1986-07-18 1986-08-28 Ici Plc Acylanilide derivatives
ES2006951A6 (es) * 1987-05-22 1989-05-16 Bracco Ind Chimica Spa Un procedimiento para la preparacion de derivados de acido 5-acilamino-2,4,6-triyodo o tribromo-benzoico.
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides
JPH07504646A (ja) * 1991-11-05 1995-05-25 ザ、ジレット、カンパニー 毛成長の速度及び特徴の変化
US5364885A (en) * 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) * 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US6743419B1 (en) 1992-12-22 2004-06-01 The Gillette Company Method of reducing hair growth employing sulfhydryl active compounds
GB9305295D0 (en) * 1993-03-15 1993-05-05 Zeneca Ltd Therapeutic compounds
GB9310095D0 (en) * 1993-05-17 1993-06-30 Zeneca Ltd Therapeutic compounds
US5648394A (en) * 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US6248751B1 (en) 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
US6414017B2 (en) 1993-05-28 2002-07-02 The Gillette Company Inhibition of hair growth
JPH0759644A (ja) * 1993-08-24 1995-03-07 Nobuyuki Yamamoto 納骨用仏像
US5474763A (en) * 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5455234A (en) * 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5468476A (en) * 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
EP0729363B1 (en) * 1994-06-27 2003-02-19 Neutron Therapies Inc. Boron-containing hormone analogs and methods of their use in imaging or killing cells having hormone receptors
US5554608A (en) * 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5674477A (en) * 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
EP0812185B1 (en) * 1995-02-28 2002-07-03 The Gillette Company Use of angiogenesis suppressors for inhibiting hair growth
US5728736A (en) * 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
FR2747039B1 (fr) * 1996-04-05 1998-05-22 Oreal Utilisation du n-(3,4-dicyano-phenyl)- 3,3,3-trifluoro- 2-hydroxy-2-methylpropionamide pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6291532B1 (en) 1996-03-06 2001-09-18 L'oreal Use of N-aryl-2-hydroxyalkylamides for stimulating or inducing hair growth and/or arresting hair loss
FR2745717B1 (fr) * 1996-03-06 1998-04-17 Oreal Utilisation de n-aryl-2-hydroxyalkylamides pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US5908867A (en) * 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
US5840752A (en) * 1996-11-21 1998-11-24 Henry; James P. Reduction of hair growth
US6995284B2 (en) * 2000-08-24 2006-02-07 The University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6492554B2 (en) 2000-08-24 2002-12-10 The University Of Tennessee Research Corporation Selective androgen receptor modulators and methods of use thereof
US7759520B2 (en) * 1996-11-27 2010-07-20 University Of Tennessee Research Foundation Synthesis of selective androgen receptor modulators
US6071957A (en) * 1996-11-27 2000-06-06 The University Of Tennessee Research Corporation Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
US20050038110A1 (en) * 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US7518013B2 (en) * 2000-08-24 2009-04-14 University Of Tennessee Research Foundation Selective androgen receptor modulators
ZA9711121B (en) * 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
US6037326A (en) * 1996-12-31 2000-03-14 Styczynski; Peter Reduction of hair growth
WO1998053826A1 (en) * 1997-05-30 1998-12-03 The University Of Tennessee Research Corporation Non-steroidal agonist compounds and their use in male hormone therapy
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6245804B1 (en) 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
WO1998055153A1 (en) * 1997-06-04 1998-12-10 The University Of Tennessee Research Corporation Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
US5939458A (en) * 1997-09-22 1999-08-17 Henry; James P. Reduction of hair growth
US5958946A (en) * 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6060471A (en) * 1998-01-21 2000-05-09 Styczynski; Peter Reduction of hair growth
GB9804648D0 (en) 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
GB9805520D0 (en) 1998-03-17 1998-05-13 Zeneca Ltd Chemical compounds
US20040176470A1 (en) * 1998-05-07 2004-09-09 Steiner Mitchell S. Method for treatment and chemoprevention of prostate cancer
GB9811427D0 (en) 1998-05-29 1998-07-22 Zeneca Ltd Chemical compounds
US6020006A (en) * 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
US6184249B1 (en) * 1998-12-18 2001-02-06 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
US6121269A (en) * 1999-02-22 2000-09-19 Henry; James P. Reduction of hair growth
WO2001017942A1 (en) 1999-09-04 2001-03-15 Astrazeneca Ab Amides as inhibitors for pyruvate dehydrogenase
AU6853700A (en) 1999-09-04 2001-04-10 Astrazeneca Ab Chemical compounds
AU760061B2 (en) 1999-09-04 2003-05-08 Astrazeneca Ab Substituted N-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity
US6235737B1 (en) * 2000-01-25 2001-05-22 Peter Styczynski Reduction of hair growth
US6299865B1 (en) 2000-05-02 2001-10-09 Peter Styczynski Reduction of hair growth
US7001911B2 (en) * 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2002000617A2 (en) * 2000-06-28 2002-01-03 Bristol-Myers Squibb Company Selective androgen receptor modulators and methods for their identification, design and use
EP1310488A4 (en) * 2000-08-09 2005-08-10 Mitsubishi Pharma Corp CONDENSED BICYCLIC AMIDE COMPOUNDS AND MEDICAL USES THEREOF
AU8523001A (en) 2000-08-24 2002-03-04 Gtx Inc Selective androgen receptor modulators and methods of use thereof
US7919647B2 (en) * 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7622503B2 (en) * 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8008348B2 (en) * 2001-12-06 2011-08-30 University Of Tennessee Research Foundation Treating muscle wasting with selective androgen receptor modulators
US20070173546A1 (en) * 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
US6838484B2 (en) * 2000-08-24 2005-01-04 University Of Tennessee Research Foundation Formulations comprising selective androgen receptor modulators
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US6998500B2 (en) * 2000-08-24 2006-02-14 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US8445534B2 (en) * 2000-08-24 2013-05-21 University Of Tennessee Research Foundation Treating androgen decline in aging male (ADAM)-associated conditions with SARMs
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US20040260108A1 (en) * 2001-06-25 2004-12-23 Dalton James T. Metabolites of selective androgen receptor modulators and methods of use thereof
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
DE10051981A1 (de) 2000-10-20 2002-05-02 Bayer Ag Substituierte Phenyluracile
WO2002062341A1 (en) * 2001-02-07 2002-08-15 University Of Florida Method and composition for the control of hair growth
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
US7439271B2 (en) 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
US6743822B2 (en) 2001-08-10 2004-06-01 The Gillette Company Reduction of hair growth
US20030036561A1 (en) * 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
US7261878B2 (en) * 2001-08-10 2007-08-28 The Gillette Company Reduction of hair growth
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
IL162340A0 (en) * 2001-12-06 2005-11-20 Gtx Inc Treating muscle wasting with selective androgen receptor modulators
BR0214933A (pt) 2001-12-13 2004-12-14 Sumika Fine Chemicals Co Ltd Cristal de bicalutamida e método de produção para o mesmo
WO2003053358A2 (en) * 2001-12-19 2003-07-03 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
US20040198821A1 (en) * 2002-01-29 2004-10-07 Hwang Cheng Shine Reduction of hair growth
US7160921B2 (en) * 2002-01-29 2007-01-09 The Gillette Company Reduction of hair growth
RS69704A (en) * 2002-02-07 2006-12-15 Gtx Inc. Treating bening prostate hyperplasia with sarms
US7803970B2 (en) * 2002-02-28 2010-09-28 University Of Tennessee Research Foundation Multi-substitued selective androgen receptor modulators and methods of use thereof
EP1487780A4 (en) * 2002-02-28 2005-11-16 Univ Tennessee Res Foundation HALOACETAMIDE AND AZID SUBSTITUTED COMPOUNDS AND METHODS OF USE THEREOF
US7772433B2 (en) * 2002-02-28 2010-08-10 University Of Tennessee Research Foundation SARMS and method of use thereof
WO2003074450A2 (en) * 2002-02-28 2003-09-12 The University Of Tennessee Research Corporation Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
US7705182B2 (en) * 2002-02-28 2010-04-27 University Of Tennessee Research Foundation Multi-substituted selective androgen receptor modulators and methods of use thereof
US20030199584A1 (en) * 2002-04-11 2003-10-23 Ahluwalia Gurpreet S. Reduction of hair growth
US7741371B2 (en) * 2002-06-17 2010-06-22 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
TW200407280A (en) * 2002-06-17 2004-05-16 Univ Tennessee Res Foundation N-bridged selective androgen receptor modulators and methods of use thereof
CA2501797A1 (en) * 2002-10-15 2004-04-29 Gtx, Inc. Treating obesity with selective androgen receptor modulators
AU2003287077B2 (en) * 2002-10-15 2007-09-20 University Of Tennessee Research Foundation Methylene-bridged selective androgen receptor modulators and methods of use thereof
US20040197928A1 (en) * 2002-10-15 2004-10-07 Dalton James T. Method for detecting selective androgen receptor modulators
US20060276539A1 (en) * 2002-10-16 2006-12-07 Dalton James T Treating Androgen Decline in Aging Male (ADAM)- associated conditions with SARMS
EP1558233A2 (en) * 2002-10-16 2005-08-03 GTX, Inc. Treating androgen decline in aging male (adam)-associated conditions with sarms
US20040087810A1 (en) * 2002-10-23 2004-05-06 Dalton James T. Irreversible selective androgen receptor modulators and methods of use thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
US20040141935A1 (en) * 2003-01-21 2004-07-22 Peter Styczynski Reduction of hair growth
US20040167103A1 (en) * 2003-02-24 2004-08-26 Dalton James T. Haloacetamide and azide substituted compounds and methods of use thereof
US7015349B2 (en) * 2003-03-26 2006-03-21 The Gillette Company Reduction of hair growth
US20050112075A1 (en) * 2003-11-25 2005-05-26 Hwang Cheng S. Reduction of hair growth
TW200533636A (en) * 2003-12-16 2005-10-16 Gtx Inc Prodrugs of selective androgen receptor modulators and methods of use thereof
US20050249685A1 (en) * 2004-04-27 2005-11-10 Natalia Botchkareva Reduction of hair growth
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20060258628A1 (en) * 2004-07-20 2006-11-16 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors, and SARMs and methods of use thereof
JP2008523159A (ja) * 2004-12-22 2008-07-03 ザ ジレット コンパニー スルビビン阻害物質による発毛の低減
CA2589875A1 (en) * 2004-12-22 2006-06-29 The Gillette Company Reduction of hair growth
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
EA016853B1 (ru) 2006-08-24 2012-08-30 Юниверсити Оф Теннесси Рисерч Фаундейшн Замещенные ациланилиды и их применение
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US9284345B2 (en) 2007-04-12 2016-03-15 Endorecherche, Inc. 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
WO2013152170A1 (en) 2012-04-04 2013-10-10 Catylix, Inc. Selective androgen receptor modulators
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9604916B2 (en) 2012-07-13 2017-03-28 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9682960B2 (en) 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995060A (en) * 1972-06-20 1976-11-30 Schering Corporation Antiandrogenic agents and method for the treatment of androgen dependent disease states
DE1793110A1 (de) * 1968-08-02 1971-12-16 Basf Ag Substituierte Saeureanilide
DE2042300A1 (de) * 1970-08-26 1972-03-23 Farbwerke Hoechst AG, vormals Meister Lucius & Brüning, 6000 Frankfurt Halogencarbonsäureanilide, ihre Herstellung und Verwendung als Herbizide
CA1012462A (en) * 1971-06-18 1977-06-21 Scherico Ltd. Pharmaceutical composition containing substituted anilides
US3875229A (en) * 1972-11-24 1975-04-01 Schering Corp Substituted carboxanilides
JPS6044294B2 (ja) * 1976-04-15 1985-10-02 帝国臓器製薬株式会社 アニリド誘導体

Also Published As

Publication number Publication date
JPH0223537B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-05-24
IL56155A0 (en) 1979-03-12
IE49866B1 (en) 1986-01-08
NO784211L (no) 1979-06-18
AU4220078A (en) 1979-06-21
US4191775A (en) 1980-03-04
IL56155A (en) 1982-09-30
JPS5495519A (en) 1979-07-28
NZ189086A (en) 1980-09-12
NO149035B (no) 1983-10-24
DK556978A (da) 1979-06-16
EP0002892A1 (en) 1979-07-11
BG31225A3 (bg) 1981-11-16
CA1123008A (en) 1982-05-04
FI783820A7 (fi) 1979-06-16
FI70007C (fi) 1986-09-12
ES476049A1 (es) 1979-05-16
AU522716B2 (en) 1982-06-24
PT68922A (en) 1979-01-01
IT7852280A0 (it) 1978-12-13
CS208112B2 (en) 1981-08-31
FI70007B (fi) 1986-01-31
DD139844A5 (de) 1980-01-23
ZA786781B (en) 1979-11-28
DE2862459D1 (en) 1985-03-21
ATA874278A (de) 1980-07-15
HU176981B (hu) 1981-06-28
EP0002892B1 (en) 1985-02-06
NO149035C (no) 1984-02-01
AT360974B (de) 1981-02-10

Similar Documents

Publication Publication Date Title
IT1107675B (it) Procedimento per la produzione di derivati ammidici in particolare acilanilidi sostituite e prodotto ottenuto
IT1110885B (it) Procedimento per la preparazione di derivati dello acido ftalazin-4-ilacetico e prodotto ottenuto
IT1093078B (it) Apparecchio e procedimento per la produzione di derivati cellulosici
IT1103464B (it) Procedimento per la produzione di derivati benzimidazolici
IT1117778B (it) Procedimento per la produzione di derivati di pirimidone e prodotto ottenuto
IT1156873B (it) Procedimento per la produzione di derivati di 1/2/4-triazin-5-one
IT7847887A0 (it) Procedimento per la produzione di derivati di benzencarbossammide e benzensolfonammide e prodotto ottenuto
IT1116858B (it) Procedimento per la preparazione di derivati isopropilenici e prodotto ottenuto
IT7850850A0 (it) Procedimento per la produzione dipicropodofillone e suoi derivati sostituiti mediante sintesi totale
IT7850500A0 (it) Derivati di norbormano e norbormene e procedimento per produrli
IT7848192A0 (it) Procedimento per la produzione di derivati di 9-2-idrossietossimetilguanina e prodotto ottenuto
IT7850879A0 (it) Derivati 25-alchilcolesterolici erelativo procedimento di produzione
IT1053979B (it) Procedimento per la produzione di beta dialogeno etenilcicopropano sostituito e prodotto ottenuto
IT7825800A0 (it) Procedimento per la fabbricazione di p-idrossifenilglicina e suoi derivati
IT1156718B (it) Procedimento per la produzione di 1-n-(omega-ammino-alfa-idrossialcanoil)kanamicine e prodotto relativo
IT1107787B (it) Procedimento per la produzione di derivati di alcaloidi pentaciclici prodotto ottenuto e relativo procedimento di impiego nella sintesi di composti della eburnamenina
IT1120407B (it) Procedimento per la preparazione di derivati di pirrolidincarbossaldeide e piperidincarbossaldeide e prodotto ottenuto
IT1113287B (it) Procedimento per la produzione di dibenzocicloottenimmine e prodotto ottenuto
IT1110876B (it) Procedimento per la preparazione di 1-idrossiaporfin derivati e prodotto ottenuto
IT7852240A0 (it) Procedimento per la preparazione di derivati di acido 1-idrocarbilpirro lo-2-acetico e prodotto ottenuto
IT1065601B (it) Procedimento per la produzione di diserbanti e prodotto ottenuto
IT1061344B (it) Procedimento per la produzione di idrossimetil idrossialchil isocianurati e prodotto ottenuto
IT1107978B (it) Procedimento per la produzione di derivati di amminoacidi alfa-acetilenici e prodotto ottenuto
IT1061216B (it) Procedimento per la produzione di xantinilalchilnortropin derivati quaternari e prodotto ottenuto
IT1103109B (it) Metodo per la produzione di 1-nitro antrachimone e prodotto ottenuto